Abstract
Background: Diltiazem HCl is a calcium channel blocker drug used in the treatment of angina pectoris and hypertension. Objective: To prepare a sustained release diltiazem HCl capsule by complexation with polystyrene sulfonate strong cation exchange resin (dowex®50wx4) as a complexing and retarding agent. Methods: The effect of stirring time and drug: resin ratio on diltiazem HCl loading on dowex®50wx4 was studied. Drug resin complexes were characterized by Fourier Transform Infrared (FT-IR) spectroscopy. The release of drug from the complexes was examined in pH 1.2 and pH 6.8 separately in comparison with pure drug and with commercially available sustained release products Tildia® 120mg capsule and BITildiem ® 120mg tablets Results and conclusion: Most efficient loading was obtained using 1:2 and 1:2.5 drug:resin ratio with stirring time of 60 and 30 minutes respectively. The resultant complexes only retard the release of diltiazem HCl when compared with pure drug while the sustained release product was obtained by coating the complex with carnauba wax and the retardation increased as a function of wax concentration. 20% of wax coated complex gave the release profile approximately similar to the marketed sustained release product of diltiazem HCl, Bi-Tildiem® (Sanofi-France) 120 mg tablets.
Highlights
MethodsThe effect of stirring time and drug: resin ratio on diltiazem HCl loading on dowex®50wx[4] was studied
Diltiazem HCl is a calcium channel blocker drug used in the treatment of angina pectoris and hypertension
The resultant complexes only retard the release of diltiazem HCl when compared with pure drug while the sustained release product was obtained by coating the complex with carnauba wax and the retardation increased as a function of wax concentration. 20%
Summary
The effect of stirring time and drug: resin ratio on diltiazem HCl loading on dowex®50wx[4] was studied. Drug resin complexes were characterized by Fourier. The release of drug from the complexes was examined in pH 1.2 and pH 6.8 separately in comparison with pure drug and with commercially available sustained release products Tildia® 120mg capsule and BITildiem® 120mg tablets
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
